Relay Therapeutics RLAY
NASDAQ RLAY
$18.34 -0.07 (-0.38%)
At close: Oct 22, 2026 · 4:00 PM EDT

Relay Therapeutics (RLAY) Ending Cash Balance (2019 - 2025)

Updated

Analysis

Relay Therapeutics (RLAY) Ending Cash Balance (2019 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Ending Cash Balance (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 16.91 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 6.57 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 6.89 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 4.88 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 3.18 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 1.03 Bn
10 Relay Therapeutics 4.01 Bn 3.51 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 85.35 Mn
Dec 31, 2024 126.41 Mn
Dec 31, 2023 146.44 Mn
Dec 31, 2022 154.37 Mn
Dec 31, 2021 282.70 Mn
Dec 31, 2020 448.52 Mn
Sep 30, 2020 560.16 Mn
Jun 30, 2020 137.93 Mn
Dec 31, 2019 42.83 Mn
Sep 30, 2019 29.92 Mn
Jun 30, 2019 40.23 Mn
API Access

Relay Therapeutics Ending Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=RLAY&period=max&api_key=YOUR_API_KEY